Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Obstetrics and Gynecology|October 8, 1999
Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trialB W Morrison, S E Daniels, P Kotey, et al.Clinical Therapeutics|November 24, 1999
Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trialK Malmstrom, S Daniels, P Kotey, et al.Antimicrobial Agents and Chemotherapy|July 8, 2009
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritisK G Naber, L Llorens, K Kaniga, et al.Journal of the American Dental Association (1939)|January 6, 2001
The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trialsB W Morrison, J Fricke, J Brown, et al.Journal of Chemotherapy (Florence, Italy)|February 10, 2011
Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritisR Redman, R Damiao, P Kotey, et al.Journal of the American Academy of Dermatology|October 26, 2000
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopeciaV H Price, J L Roberts, M Hordinsky, et al.Pageof 1